VANGUARD GROUP INC

Holdings History for Aprea Therapeutics, Inc. - Common stock, par value $0.001 per share (APRE)

Symbol: APRE on Nasdaq
Investment type: Equity / Common stock, par value $0.001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	-0%	$49,548	58,086	-100,152	-63%	$0.85	Q4 2025
30 Sep 2025	0%	0%	$233,401	158,238	-15,604	-9%	$1.47	Q3 2025
30 Jun 2025	0%	0%	$295,531	173,842	0		$1.70	Q2 2025
31 Mar 2025	0%	0%	$354,638	173,842	0		$2.04	Q1 2025
31 Dec 2024	0%	0%	$570,202	173,842	0		$3.28	Q4 2024
30 Sep 2024	0%	+0%	$478,066	173,842	+58,004	+50%	$2.75	Q3 2024
30 Jun 2024	0%	0%	$471,461	115,838	-140	-0.12%	$4.07	Q2 2024
31 Mar 2024	0%	+0%	$775,893	115,978	+81,290	+234%	$6.69	Q1 2024
31 Dec 2023	0%	+0%	$163,034	34,688	+7,347	+27%	$4.70	Q4 2023
30 Sep 2023	0%	+0%	$113,916	27,341	+11,840	+76%	$4.17	Q3 2023
30 Jun 2023	0%	0%	$48,828	15,501	0		$3.15	Q2 2023
31 Mar 2023	0%	+0%	$68,826	15,501	+15,501	NEW	$4.44	Q1 2023

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.